genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 6.40
+0.12 (1.91%)
At close: Mar 6, 2026
genXone Market Cap
genXone has a market cap or net worth of 21.15 million as of March 6, 2026. Its market cap has decreased by -13.28% in one year.
Market Cap
21.15M
Enterprise Value
17.79M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 21.15M, a decrease of -85.07%. That is a compound annual growth rate of -29.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 21.15M | 60.40% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.12B |
| NEUCA | 3.38B |
| Synektik Spólka Akcyjna | 2.52B |
| Voxel | 1.39B |
| Pharmena | 35.64M |
| Medicofarma Biotech | 32.43M |
| Airway Medix | 29.78M |
| Pure Biologics | 29.78M |